We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Events

06 Aug 2025 - 08 Aug 2025
19 Aug 2025 - 21 Aug 2025
21 Aug 2025 - 23 Aug 2025

AI Tool Detects Cancerous Brain Tumor During Surgery in 10 Seconds

By HospiMedica International staff writers
Posted on 14 Nov 2024

When brain tumors recur, survival rates decrease, and patients with the most aggressive tumor types often pass away within a year. More...

This happens because cancerous tissue remains after the initial surgery, and it continues to grow, sometimes at a faster rate than the original tumor. Residual tumors not only result in a lower quality of life and premature death for patients but also contribute to the burden on healthcare systems, which are projected to handle 45 million annual surgical procedures by 2030. Now, an artificial intelligence (AI)-based diagnostic system has been developed to detect cancerous tissue that might otherwise go unnoticed during brain tumor surgery. This technology allows neurosurgeons to remove the cancerous tissue while the patient is still under anesthesia or treat it afterward with targeted therapies.

In a new study, led by UC San Francisco (San Francisco, CA, USA) and University of Michigan (Ann Arbor, MI, USA), researchers demonstrated how an AI-powered diagnostic tool aids neurosurgeons in identifying hidden cancer that has spread nearby. This technique holds the potential to delay the recurrence of high-grade tumors and may even prevent recurrence in lower-grade tumors. The tool, called FastGlioma, is open-source and patented by UCSF, but it has not yet been approved by the Food and Drug Administration. FastGlioma combines AI’s predictive capabilities with stimulated Raman histology (SRH), an imaging technology that allows fresh tissue samples to be visualized at the bedside within one to two minutes. This rapid process bypasses the time-consuming procedures typically required in pathology labs for processing and interpreting tumor cells.

The AI system was trained using a dataset of over 11,000 tumor specimens and 4 million microscopic images, allowing it to accurately classify images and distinguish between tumor and healthy tissue. Neurosurgeons can receive diagnostic results within 10 seconds, enabling them to continue surgery if necessary. In the study published in Nature, neurosurgeons examined tumor samples from 220 patients with high-grade and low-grade diffuse gliomas, the most common type of adult brain tumor. The study found that 3.8% of patients who used FastGlioma had remaining high-risk tissue, compared to 24% of patients who did not use the tool. The study suggests that similar AI techniques could be tested in surgeries for other cancers, including breast, lung, prostate, and head and neck cancers.

“FastGlioma has the potential to change the field of neurosurgery by immediately improving comprehensive management of patients with glioma,” said senior author Todd Hollon, MD, of the Department of Neurosurgery at University of Michigan. “The technology works faster and more accurately than current standards of care methods for tumor detection and could be generalized to other pediatric and adult brain tumor diagnoses.”


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
Mobile X-Ray System
K4W
New
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Schematic of approach to simulating brain shunt fluid dynamics (Photo courtesy of Haritosh Patel/Harvard SEAS)

Computational Model Accurately Simulates Shunt Performance to Prevent Repeat Surgeries

Millions of people worldwide suffer from hydrocephalus, a condition characterized by the buildup of excess cerebrospinal fluid in the brain. Treatment typically involves the surgical placement of shunts... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: A research collaboration aims to further advance findings in human genomics research in cardiovascular diseases (Photo courtesy of 123RF)

Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies

A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.